Paper219345
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.
Yoon JW and 3 others. N Engl J Med, 1979. Cited by 850 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. Papers, record 219345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219345
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coxsackievirus Infections | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Diabetic Ketoacidosis | Major topic |
| Enterovirus B, Human | Major topic |
| Islets of Langerhans | Major topic |
| Animals | |
| Antibodies, Viral | |
| Child | |
| Diabetes Mellitus | |
| Humans | |
| Male | |
| Neutralization Tests | |
| Viral Plaque Assay | |
| Virus Cultivation |
Source PubMed
Cited by262
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 850 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,795,466 | Hyperglycemia in Cats Infected by SARS-CoV-2: Pancreatic Alterations and Potential Antiviral Therapeutics. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795466 | PubMed |
| 42,394,369 | Interplay Between Infectious Diseases and the Endocrine System: An Overview and Clinical Insights. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/42394369 | PubMed |
| 41,754,571 | Oral Immunization with the C488A Live-Attenuated Mutant of Coxsackievirus B4E2 (CVB4E2) Induces Potent Immune Response and Protects Balb/c Mice Against Lethal Infection. | Viruses | 2026 | https://conductscience.org/library/papers/41754571 | PubMed |
| 41,662,565 | Distinct Enterovirus Antigen Landscape in Children With Islet Autoimmunity. | Diabetes | 2026 | https://conductscience.org/library/papers/41662565 | PubMed |
| 41,522,881 | Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo. | NAR Mol Med | 2026 | https://conductscience.org/library/papers/41522881 | PubMed |
| 40,090,994 | Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue. | Diabetologia | 2025 | https://conductscience.org/library/papers/40090994 | PubMed |
| 40,060,384 | Infections and antibiotic use in early childhood have limited importance in developing manifest type 1 diabetes - The ABIS cohort study. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40060384 | PubMed |
| 39,614,711 | Human Primary Macrophages Can Transmit Coxsackie B4 Virus to Pancreatic Cells In Vitro. | J Med Virol | 2024 | https://conductscience.org/library/papers/39614711 | PubMed |
| 39,211,046 | Antigen-specific T cell responses in autoimmune diabetes. | Front Immunol | 2024 | https://conductscience.org/library/papers/39211046 | PubMed |
| 38,551,145 | Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/38551145 | PubMed |
| 38,444,587 | Animal models for type 1 and type 2 diabetes: advantages and limitations. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38444587 | PubMed |
| 38,023,309 | Experimental diabetic animal models to study diabetes and diabetic complications. | MethodsX | 2023 | https://conductscience.org/library/papers/38023309 | PubMed |
| 37,987,794 | Current advancement in the preclinical models used for the assessment of diabetic neuropathy. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37987794 | PubMed |
| 37,940,619 | COVID-19 induced type 1 diabetes: A systematic review of case reports and series. | J Int Med Res | 2023 | https://conductscience.org/library/papers/37940619 | PubMed |
| 37,725,516 | Severe pneumonia and pathogenic damage in human airway epithelium caused by Coxsackievirus B4. | Emerg Microbes Infect | 2023 | https://conductscience.org/library/papers/37725516 | PubMed |
| 37,317,166 | Cloning and Molecular Characterization of the Recombinant CVB4E2 Immunogenic Viral Protein (rVP1), as a Potential Subunit Protein for Vaccine and Immunodiagnostic Reagent Candidate. | Microorganisms | 2023 | https://conductscience.org/library/papers/37317166 | PubMed |
| 37,227,147 | Assessment of Enterovirus Antibodies during Early Childhood Using a Multiplex Immunoassay. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37227147 | PubMed |
| 37,112,858 | Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model. | Viruses | 2023 | https://conductscience.org/library/papers/37112858 | PubMed |
| 37,064,445 | Diabetogenic viruses: linking viruses to diabetes mellitus. | Heliyon | 2023 | https://conductscience.org/library/papers/37064445 | PubMed |
| 36,177,022 | Plasma-derived exosomal mRNA profiles associated with type 1 diabetes mellitus. | Front Immunol | 2022 | https://conductscience.org/library/papers/36177022 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/219345
GET https://conductscience.org/api/papers/v1/219345/cited_by?page=2